Does a knockout of NDUFA2 Lead to Parkinson’s Disease?

Slides:



Advertisements
Similar presentations
Overview of oxidative phosphorylation
Advertisements

1 Recombinant DNA Dr. R. Howells May 1, 2015 Dental Biochem Lecture 38.
PDbase : A database of Parkinson’s Disease-related genes and genetic variation using substantia nigra ESTs Jin Ok Yang Korean BioInformation Center (KOBIC)
Gene Expression and Regulation
“CRISPR genome editing” Precise gene regulation/modification using the simple CRISPR/Cas9 system Thank you. Nucleeases will be used as a new tool that.
The case:  2005: No production Continued sampling  2006: Detected plants expressing transgene - demonstrated pollen transfer and seed dispersal (Reichman.
Parkinson’s and Calcium Channels
吳 華 席 Hua-Hsi Wu, MD OB/GYN, VGH-TPE Aug 12, 2008
Mitochondria in the etiology and pathogenesis of Parkinson's disease
Lecture-7 Genome editing CRISPR
Α-synuclein transgenic mouse models of Parkinson’s disease Michelle Maurer December 2015.
Mutations in MCL-1 PEST Region of Breast Cancer on Binding Affinity to Bak/Bax Deeksha Jain.
KEY AREA 7: Cellular Respiration
Breton J, et al Brenda Quijas
What do we need to know to become stem cell literate?
Does a knockout of NDUFA2 Lead to Parkinson’s Disease?
Mutations in MCL-1 PEST Region of Breast Cancer on Binding Affinity to Bak/Bax Deeksha Jain.
Genome editing to breed better plants
Use of CRISPR/Cas to edit the Arabidopsis Na+/H+ Antiporter NHX1
Institute of Health and Biomedical Innovation
Cx43 Mediates Resistance against MPP+ -Induced
Alexander Kena, Heng Ye, Jiuhuan Feng, Xingyou Gu
Presented By: Diana Marquez
Nitric Oxide (NO) and How it Regulates Motor Function
Genome Editing and Gene Drive at UCI
Assessing the role of the ALS-associated gene NEK1 in zebrafish motor neuron development Amy Stark.
Mutations & Genetic Engineering
Manipulating an organism’s genome using biotechnology
“Proteomics is a science that focuses on the study of proteins: their roles, their structures, their localization, their interactions, and other factors.”
CRISPR + CAS = Defensive or Immune System
Understanding the structure of a protein involved in Parkinson’s disease -My research proposal was “Relating the structure of aggregated alpha synuclein.
Dieter Steinmetz Universität Tübingen – ZMBP Kurs WS 15/16
Parkinson’s Diseased Proteins in Relation to Autophagy
CRISPR/Cas9 Clustered Regularly Interspaced Short Palindromic Repeats
CRISPR/Cas9 GENOMICS Lucía Álvarez González
Volume 56, Issue 4, Pages (November 2014)
Volume 16, Issue 3, Pages (September 2012)
Understanding the structure of a protein involved in Parkinson’s disease -My research proposal was “Relating the structure of aggregated alpha synuclein.
STP2 & GAPDH: Partners in crime towards -Synuclein Toxicity
Genome editing by CRISPR
CRISPR CRISPRs (clustered regularly interspaced short palindromic repeats) are repetitive nucleotide sequences followed by a short spacer DNA segments.
Harnessing CRISPR–Cas systems for bacterial genome editing
The CRISPR/Cas9 system.1 Clustered regularly interspaced palindromic repeats (CRISPR) refers to sequences in the bacterial genome. The CRISPR/Cas9 system.1.
Parkinson's Disease Neuron
Research Techniques Made Simple: The Application of CRISPR-Cas9 and Genome Editing in Investigative Dermatology  Joan Ramon Guitart, Jodi L. Johnson,
Figure 1 Adaptive immune system of bacteria and archaea
Therapeutic editing of hepatocyte genome in vivo
Alzheimer’s Disease and the influence of Presenilin 1
The CRISPR/Cas9 system.1 Clustered regularly interspaced palindromic repeats (CRISPR) refers to sequences in the bacterial genome. The CRISPR/Cas9 system.1.
Joseph Bondy-Denomy, Alan R. Davidson  Trends in Microbiology 
RNAi: Prokaryotes Get in on the Act
CRISPR: What is it? Biotech Ethics, Fall ‘18.
General strategy for organelle-based proteomics: example of cardiac mitochondria.Top left, validation of organelle-specific proteins occurs at two independent.
Mass spectrometry identification of spots in 2D blue native gels of cytoplasmic membranes isolated from BL21(DE3)pLysS Spots in 2D BN gels of cytoplasmic.
Characterization of aggregates isolated from E
Figure 1 Oxidative phosphorylation
Gene transfer © 2016 Paul Billiet ODWS.
Zhao Zhang, Yuelin Zhang, Fei Gao, Shuo Han, Kathryn S
A CRISPR Approach to Gene Targeting
William T. Hendriks, Curtis R. Warren, Chad A. Cowan  Cell Stem Cell 
Structure of an RNA Silencing Complex of the CRISPR-Cas Immune System
CRISPR-Based Technologies for Metabolic Engineering in Cyanobacteria
Gene editing: modifying a gene that was already there
Volume 13, Issue 3, Pages (October 2015)
Chemical Biology Approaches to Genome Editing: Understanding, Controlling, and Delivering Programmable Nucleases  Johnny H. Hu, Kevin M. Davis, David R.
Volume 20, Issue 6, Pages (December 2014)
Figure 3 Patient cells show impaired OXPHOS complex levels and function Patient cells show impaired OXPHOS complex levels and function (A) SDS-PAGE and.
Protein Phosphorylation and Prevention of Cytochrome Oxidase Inhibition by ATP: Coupled Mechanisms of Energy Metabolism Regulation  Rebeca Acin-Perez,
Presentation transcript:

Does a knockout of NDUFA2 Lead to Parkinson’s Disease? Ruairidh Barlow

What is Parkinson's Disease (PD)? Age related neurodegenerative disease Symptoms: tremors, stiffness, and slow movement

MPP+ Induces Parkinson’s Symptoms

? BINDS AND INHIBITS Complex I NADH: ubiquinone oxidoreductase Knockout NDUFA2 MPP+ Null DJ-1 ? NADH: ubiquinone oxidoreductase Complex I catalyzes the transfer of electrons from NADH to coenzyme Q10 Complex I is made up of 44 protein subunits Dysfunction Dysfunction BINDS AND INHIBITS

Does A Knockout of NDUFA2 Cause Symptoms Found In PD? Gene knockout Measure effects of knock out Levels of cellular oxygen consumption Mitochondrial membrane potential Level of ATP synthesis Compare results between cell types (control, experimental PD) Parkinson’s? CRISPR NDUFA2

CRISPR/Cas9 Clustered regularly interspaced short palindromic repeats (CRISPR) State of the art gene editing procedure Derived from E. coli CRISPR Associated genes (Cas) Primarily helicase and nuclease

Knockout Procedure gRNA Design (Guiding RNA) 19 – 25 nucleotides long NDUFA2 Target sequence Knockout Procedure PAM gRNA Design (Guiding RNA) 19 – 25 nucleotides long Adjacent to a 5’-NGG-3’ proto-spacer motif (PAM) Complement to target sequence NDUFA2 target sequence “CCAGAGCTTGGGCTGCACAT”

Knockout Procedure gRNA Design Cloning of Oligo (gRNA) into a CRISPR/Cas9 Nuclease Vector

NO TIME TO TALK ABOUT THESE STEPS Knockout Procedure gRNA Design Cloning of Oligo (gRNA) into a CRISPR/Cas9 Nuclease Vector Infection of Cell Line NO TIME TO TALK ABOUT THESE STEPS

Refresher What are you trying to do? Knockout NDUFA2 What’s the purpose in making a knockout? Observe the effects this knockout will have on a cell Does the cell exhibit PD cell traits? What do you want to measure? Cell oxygen consumption Mitochondrial Membrane potential Levels of ATP synthesis

Isolation of Mitochondria

Complex I Intact in a NDUFA2 knockout? Blue native-polyacrylamide gel electrophoresis (BN-PAGE) One dimensional: Mitochondrial supercomplexes (Complex I) Allows for separation of protein complex Preserves protein subunit interaction

Complex I Intact in a NDUFA2 knockout? Two dimensional SDS- PAGE: Complex subunits Was the knockout a success? Breaks down complexes into individual subunits Protein subunits are visualized by silver staining

Native Gel Dimension +Detergent

What Is Hoped To Be Seen Control, all subunits present Knockout, missing subunit

Measuring Effect of Knockout Cell oxygen consumption Mitochondrial Membrane potential Levels of ATP synthesis DON’T HAVE TIME, READ IN PROPOSAL

Discussion By comparing oxygen consumption levels, membrane potential, and rate of ATP synthesis between the three cell types it can be determined what, if at all, the impact a knockout of NDUFA2 will have on a cell The results from this experiment will help to further our understanding of NDUFA2’s potential role in Parkinson’s disease. This information will help determine whether Parkinson’s is just the expression of complex I dysfunction in dopaminergic neurons

Questions?

References de Lau LM, Breteler MM. Epidemiology of Parkinson’s disease. Lancet Neurol 2006;5:525-535. Tanner, C. M., & Aston, D. A. (2000). Epidemiology of Parkinsonʼs disease and akinetic syndromes. Current Opinion in Neurology, 13(4), 427-430. doi:10.1097/00019052- 200008000-00010 Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 2015;30:1591-1601. Wirth, C., Brandt, U., Hunte, C., & Zickermann, V. (2016). Structure and function of mitochondrial complex I. Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1857(7), 902- 914. doi:10.1016/j.bbabio.2016.02.013 NDUFA2 NADH:ubiquinone oxidoreductase subunit A2 [Homo sapiens (human)] - Gene - NCBI. (n.d.). Retrieved April 15, 2017, from https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=ShowDetailView&TermToSearch=4695 Heo, J. Y., Park, J. H., Kim, S. J., Seo, K. S., Han, J. S., Lee, S. H., . . . Kweon, G. R. (2012). DJ-1 Null Dopaminergic Neuronal Cells Exhibit Defects in Mitochondrial Function and Structure: Involvement of Mitochondrial Complex I Assembly. PLoS ONE, 7(3). doi:10.1371/journal.pone.0032629 (n.d.). Retrieved April 15, 2017, from https://www.atum.bio/eCommerce/cas9/input NDUFA2 - human gene knockout kit via CRISPR. (n.d.). Retrieved April 29, 2017, from http://www.origene.com/CRISPR-CAS9/KN202715/NDUFA2.knockout Bao, L., Chen, S., Conrad, K., Keefer, K., Abraham, T., Lee, J. P., . . . Miller, B. A. (2016). Depletion of the Human Ion Channel TRPM2 in Neuroblastoma Demonstrates Its Key Role in Cell Survival through Proteomics, C. (n.d.). 2D Blue Native. Retrieved April 29, 2017, from http://www.creative-proteomics.com/services/2d-blue-native-sds-page-for-complex-analysis.htm Fiala, G. J., Schamel, W. W., Blumenthal, B. Blue Native Polyacrylamide Gel Electrophoresis (BN-PAGE) for Analysis of Multiprotein Complexes from Cellular Lysates. J. Vis. Exp. (48), e2164, doi:10.3791/2164 (2011). University of Virginia School of Medicine. (n.d.). Retrieved April 29, 2017, from https://pharm.virginia.edu/facilities/seahorse-xf24-extracellular-flux-analyzer/ Vives‐Bauza, C., Yang, L., & Manfredi, G. (2007). Assay of Mitochondrial ATP Synthesis in Animal Cells and Tissues. Mitochondria, 2nd Edition Methods in Cell Biology, 155-171. doi:10.1016/s0091-679x(06)80007-5 Hodge, G. K., & Butcher, L. L. (1980). Pars compacta of the substantia nigra modulates motor activity but is not involved importantly in regulating food and water intake. Naunyn- Schmiedeberg's Archives of Pharmacology, 313(1), 51-67. doi:10.1007/bf005058